Status:
UNKNOWN
Superior Hypogastric Plexus Block Versus Pulsed Radiofrequency for Chronic Pelvic Cancer Pain
Lead Sponsor:
Assiut University
Conditions:
Chronic Pelvic Cancer Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Cancer-related pain represents a major challenge for both clinicians and patients. This pain can be associated directly with the cancer or with certain treatments administered to the patient. 52.1% of...
Detailed Description
pelvic cancer is a broad term encompassing malignant tumors of the bladder, prostate, cervix, endometrium, ovaries, and uterus, among others. Pain associated with pelvic cancer is one of the most debi...
Eligibility Criteria
Inclusion
- sympathetically maintained pelvic, perineal pain
- pain is no longer controlled with oral morphine sustained release tablets 30 mg
- excessive sedation or other side effects from oral morphine sustained release tablets 30 mg or amitryptyline tablets 25 mg
- age between 18-70 years
Exclusion
- patient refusal
- patients with coagulopathies
- allergy to constant dyes or phenol
- patients receiving radiation or chemotherapy within 4 weeks of neurolytic block
- patients with major or moderate cardiac/respiratory incapacitating diseases
- liver and renal failure
- patients younger than 18 years and older than 70 years
Key Trial Info
Start Date :
October 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03228316
Start Date
October 20 2019
End Date
December 20 2020
Last Update
July 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.